|

EP2/EP4 Antagonist TPST-1495 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Dual EP2/4 Antagonist TPST-1495, PGE2 EP2/EP4 Receptor Antagonist TPST-1495, Prostaglandin E2 Receptor EP2/EP4 Antagonist TPST-1495, TPST 1495, TPST-1495 +1 more

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Familial Adenomatous Polyposis1
  • Colorectal Carcinoma1
  • Cancer1

Phoenix, Arizona1 trial

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Mayo Clinic Hospital in Arizona

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.